Beauty

Shiseido to sell Aupres owner SLC to IDG-led consortium

Dalia MansourNovember 19, 20265 min read0 views

At a glance

  • The binding agreement gives IDG-managed funds 95% of the China subsidiary while SLC's incoming management holds 5%, as Shiseido narrows its brand priorities.
  • Shiseido has agreed to sell Shiseido Liyuan Cosmetics, the Chinese subsidiary behind Aupres, to an IDG Capital-led consortium, with closing expected between late 2026 and early 2027. The divestment forms part of the group's 2030 strategy to improve profitability and focus resources on higher-growth priorities in China.
Unbranded cosmetics jars and a small factory model sit on a split studio set, suggesting a beauty brand business changing hands.

Shiseido has signed a binding agreement to sell its Chinese subsidiary Shiseido Liyuan Cosmetics (SLC) to an investor consortium led by Hong Kong-based private equity firm IDG Capital. SLC makes and sells the Aupres brand in China, and the transaction covers the entire company.

The deal is expected to close between the fourth quarter of 2026 and the first quarter of 2027, subject to regulatory approvals including in China. Shiseido did not disclose financial terms.

The sale is part of Shiseido's effort to improve profitability and capital efficiency under its 2030 Medium-Term Strategy. The company said it wants to drive sustainable growth and strengthen its competitiveness in China by focusing management resources on areas where it enjoys the greatest competitive advantage.

Why Shiseido is exiting

According to Shiseido, SLC requires continued investment in product innovation and digital capabilities. Divesting the business allows the group to concentrate on priority brands and higher-growth opportunities. Shiseido described China as a strategically important and attractive market, while noting that the competitive landscape is evolving with rapid e-commerce expansion, changing consumer behavior and the emergence of diverse market participants.

SLC was established in 1991 as a joint venture with Beijing Liyuan, a subsidiary of Yiqing Group, which is owned by the Beijing Municipal Government. SLC has sold the C-beauty brand Aupres since 1994. With the current joint venture agreement set to expire in December 2026, the parties agreed not to renew it. On September 1, 2026, Shiseido acquired Beijing Liyuan's 35% stake, giving it full ownership before the sale.

Ownership and handover

Under the transaction, funds managed by IDG Capital will take 95% of the equity through two special purpose vehicles. A limited partnership enterprise set up mainly by SLC's new management team will hold the remaining 5%. The deal includes SLC's Beijing factory and production equipment.

Shiseido said it believes independent operation under IDG will support SLC's sustainable growth and brand value. To ensure a smooth handover, Shiseido will license the intellectual property rights IDG needs to run the business. For a specified period after the transfer, Shiseido will also provide support on new product development, technical assistance for the stable supply of existing products, and continued supply of raw materials and selected products.

The company said the remaining collaboration is intended to maintain SLC's innovation capabilities, product quality and business continuity.

Profit recovery context

The divestment comes days after Shiseido reported a 124.3% jump in core operating profit for the third quarter of 2026, to ¥67.5 billion (US$422.13 million). The company attributed the recovery to restructuring, cost cuts and improved margins rather than strong product demand; like-for-like sales grew 0.7%.

Shiseido raised its full-year core operating profit forecast from ¥59 billion (US$433 million) to ¥87 billion (US$546 million) on the back of those results.

Reported by Dalia Mansour, Beauty Product Sourcing Analyst.